Innocan Pharma Corporation reported another clinical success in its Canine (dogs) Compassionate Care Trial, resulting in improving walking abilities and significant decrease in pain in participating canines. "Lady", an 11-year-old spayed dachshund-mixed dog was suffering from severe autoimmune mediated polyarthritis that resulted in an almost complete inability to walk, accompanied by severe pain and an overall disability. "Lady", an 11-year-old spayed dachshund-mixed dog was suffering from severe autoimmune mediated polyarthritis that resulted in an almost complete inability to walk, accompanied by severe pain and an overall disability.
Innocan Pharma Reports Clinical Success in Canine Compassionate Care Trial
February 21, 2023 at 07:37 am EST
Share
Share
© S&P Capital IQ - 2023